Alan Breier, MD, is affiliated with the Psychiatry Department at Indiana University School of Medicine in Indianapolis. From 2000 to 2025, Breier has published extensively on schizophrenia and schizoaffective disorders, focusing on pharmacological treatments including antipsychotic efficacy and safety, as well as agitation management. His work also encompasses neurology, dementia, genetics, and sexual dysfunction, with studies addressing treatment response genetics and quality of life in psychiatric populations. Breier frequently collaborates with co-authors such as Peter D. Feldman and Steven M. Paul.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
